Key Highlights

  • Intertek runs one of the world's largest testing, inspection and certification (TIC) networks — a sprawling empire of laboratories that checks everything from the safety of toys and textiles to the integrity of oil pipel...
  • It is precisely the kind of Business that thrives as regulation multiplies and Supply chains grow more complex.
  • The terms offer 6,108p (£61.08) per share in cash and dividends, an Equity value of roughly £9.5bn and a premium of around 40% to Intertek's undisturbed price on 15 April 2026.
  • EQT is drawing co-investment from Gulf sovereign wealth, with the Abu Dhabi Investment Authority and Mubadala anticipated to hold minority stakes of about 16% and 8% respectively.

Intertek runs one of the world's largest testing, inspection and certification (TIC) networks — a sprawling empire of laboratories that checks everything from the safety of toys and textiles to the integrity of oil pipelines and the quality of food. It is precisely the kind of business that thrives as regulation multiplies and supply chains grow more complex. In 2026 that appeal proved irresistible to private equity: on 18 June, Swedish group EQT agreed a recommended cash Acquisition valuing Intertek at about £10.9bn including Debt — one of the year's largest take-privates from the London market, and a direct twist on the supplied headline's premise that a listed champion would keep compounding in public hands.

The deal

The terms offer 6,108p (£61.08) per share in cash and dividends, an equity value of roughly £9.5bn and a premium of around 40% to Intertek's undisturbed price on 15 April 2026. EQT is drawing co-investment from Gulf sovereign wealth, with the Abu Dhabi Investment Authority and Mubadala anticipated to hold minority stakes of about 16% and 8% respectively. Several shareholders had publicly urged the board to engage, and the recommended deal, structured to complete later in 2026 subject to regulatory approvals, would remove another Blue-Chip name from the LSE at a time when the exchange has struggled to retain its largest constituents. The all-cash structure means holders crystallise value at a fixed price rather than participating in any future upside, so the shares now largely track the probability and timing of completion rather than the group's trading performance. The involvement of deep-pocketed sovereign co-investors also signals confidence in the long-term cash generation of the asset.

Why regulation is the prize

The rationale echoes the headline's angle: rising regulation is a structural tailwind for TIC. Tightening standards on product safety, sustainability, chemicals, cyber security and supply-chain transparency force manufacturers and retailers to test more, more often, and across more jurisdictions. Intertek's global lab footprint, trusted brands and recurring, largely non-discretionary Revenue make it a classic 'picks-and-shovels' play on regulation and trade — exactly the defensive, cash-generative profile private Capital prizes, and one EQT argues can be nurtured harder away from the constraints of quarterly public-market reporting. The long-term contracts and switching costs embedded in accreditation relationships add to the visibility of future earnings.

Financial position

Intertek came to the deal in good health. Under chief executive Andre Lacroix it had delivered years of Margin progress and reliable cash generation, and in its 2026 half-year results the company reported double-digit profit growth while Withholding an interim Dividend ahead of the EQT transaction. The group spans Consumer Products, Corporate Assurance, Health & Safety, Industry & Infrastructure and World of Energy, giving it Diversification across both consumer-facing and industrial end-markets and a spread of geographies that smooths cyclical swings — a resilience that helped justify the premium on offer and reassured EQT of the stability of the cash flows it is financing. Withholding the Interim Dividend is a routine feature of a bid under the UK Takeover rules, preserving the agreed offer value rather than signalling any deterioration in trading.

Outlook

The takeover fits a wider pattern of private-equity and overseas buyers picking off UK-listed quality at valuations they consider cheap relative to global peers, thinning the FTSE 100's roster of world-class compounders. Risks now centre on completion rather than trading: regulatory and antitrust clearances, and the small chance of a rival bid or Shareholder pushback on price, are the remaining variables, though the recommendation and 40% premium make disruption unlikely. Longer term, the debate is whether public investors are surrendering a durable growth asset too cheaply, just as the regulatory tide that powers its business is rising. Investors may watch for the scheme timetable, any competing interest, and confirmation of the sovereign co-investors' roles. Barring surprises, one of the LSE's steadiest global champions is on course to disappear into private ownership.